Parkinson Research Updates — Dr. Lungu
Main Points:
Key recent and active developments in understanding PD include disease heterogeneity, its involvement of the whole body, and the importance of the prodromal period.
Progress in symptomatic therapy of both motor and non-motor features has improved therapeutic options.
Active research in disease-modifying therapy includes gene therapy, GLP-1 agonists, exercise, and others.
Participation in clinical trials is key to research progress, but it needs to be undertaken with a clear understanding of what research studies are
Thank you to those who made a donation above their registration fee in support of the PFNCA Symposium. If you have not done so and would like to make a donation, please click here.
To view the full list of available lectures please click here.
Each year, the PFNCA Medical Advisory Board produces a conference to share the latest on treatments, medications, research and more with you.
This year the 2024 PFNCA Symposium will take place online starting May 18th.